Year: 2021

Panostaja Oyj         Stock Exchange Bulletin, Changes in Management        November 4, 2021        10.00 a.m. Grano’s CEO changes The Board of Directors and CEO of Grano, Panostaja´s investment target, have mutually agreed that CEO Pekka Mettälä will leave his position of Grano’s CEO. The company´s Board of Directors has appointed Kimmo Kolari, Vice President, as the company’s interim CEO and initiated the application process for a new CEO. “On behalf of the entire Board, I would like to thank Pekka for his very valuable contribution to Grano. Under Pekka’s leadership, the company has sharpened its strategy, initiated a change towards a comprehensive service company and invested heavily in customer experience and a people-centred culture. Thanks to these, the next steps in Grano’s development can be...

Oslo, 4 November 2021: Scatec ASA (“Scatec”) has mandated DNB Markets, Nordea and Swedbank to arrange a series of fixed income investor meetings commencing Monday, 8 November 2021. A EUR denominated senior unsecured green bond issue with a 5-year maturity may follow, subject to inter alia market conditions. For further information, please contact:Mikkel Tørud, CFO, tel: +47 976 99 144,Andreas Austrell, VP IR, tel: +47 974 38 686 About Scatec ASA:Scatec is a leading renewable power producer, delivering affordable and clean energy worldwide. As a long-term player, Scatec develops, builds, owns and operates solar, wind and hydro power plants and storage solutions. Scatec has more than 3.5 GW in operation and under construction on four continents and more than 500 employees. Scatec is targeting 15 GW capacity in operation or under...

Majority (83%) plan to spend less or the same this Christmas as last year Third (31%) of Brits worried about Christmas supply chain issues with 30% stockpiling in October to avoid disappointment Overall, 38% of Brits do not feel confident that it will be safe to travel during the festive periodLONDON, Nov. 04, 2021 (GLOBE NEWSWIRE) — Research carried out by Momentive (formerly SurveyMonkey), a leader in agile experience management, exploring consumers’ concerns and expectations regarding Christmas shopping and travel plans, reveals that over half (57%) of UK adults don’t plan to travel this Christmas, with a third (31%) cancelling their Christmas plans entirely due to COVID-19 uncertainty and concerns around safety. Uncertainty causing many to cancel Christmas travel plansWith over 79.2% of the population over the age of 12...

The Phase 1 clinical trial was conducted by The King Abdullah International Medical Research Centre (KAIMRC), in the Kingdom of Saudi Arabia (KSA), in partnership with the University of Oxford. Vaccitech retains commercial rights to this vaccine. The ChAdOx1 MERS vaccine candidate was generally well tolerated and induced both humoral and cellular immune responses, which continued through the six-month follow-up period. Study published online in The Lancet Microbe (https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(21)00193-2/fulltext). OXFORD, United Kingdom, Nov. 04, 2021 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer, today...

SHENZHEN, China, Nov. 04, 2021 (GLOBE NEWSWIRE) — Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading digital insurance product and service platform for new generation consumers in China, today announced that it will hold its annual general meeting (the “AGM”) of shareholders at 49/F, Building T1, Qianhai Financial Centre, Linhai Avenue, Qianhai Shenzhen-Hong Kong Cooperation Zone, Shenzhen 518000, People’s Republic of China, on December 2, 2021 at 10:00 a.m. (Beijing time). No proposal will be submitted for shareholder approval at the AGM. Instead, the AGM will serve as an open forum for shareholders and beneficial owners of the Company’s American depositary shares to discuss the Company affairs with our management team. The board of directors of the Company has fixed the close of business on November...

CoinShares delivers strongest third quarter financial results in the Group’s history SAINT HELIER, Jersey, November 4, 2021 – CoinShares International Limited (Nasdaq First North Growth Market: CS) (“CoinShares”, the “Group” or the “Company”) today released its financial results and operational updates for the third quarter and nine-months ended 30 September 2021. The full report, which is linked in this press release, can also be found on the CoinShares Investor Relations site. Financial Results Summary Following the Group’s record Q2 results as announced on 5 August 2021, CoinShares achieved a record Q3, resulting in the strongest nine-month performance in the Group’s history. The financial highlights for the period ended 30 September 2021 include:Total comprehensive income of £84.9 million(2020 comparative: £14.3 million; 2020 full...

Press release – Paris, November 4th, 2021 Changes in the shareholding of SMCP – Changes in the total number of voting rights Following the temporary taking of possession by the Trustee of the exchangeable bonds issued by European Topsoho S.à r.l. of part of the SMCP shares pledged under these exchangeable bonds (21,952,315 SMCP shares corresponding to approximately 29% of the share capital of SMCP – see press release of October 29, 2021) and a disposal by European Topsoho S.à r.l. of 12,106,939 unpledged SMCP shares, the number of voting rights attached to the SMCP shares is modified as follows:Information closing date Total number of shares forming the share capital* Total number of voting rightsOctober 31, 2021 75,697,640   Allocated as follows: Ordinary shares: 74,798,149Preferred shares: 899,491   ...

Rueil Malmaison, 4 November 2021 VINCI wins the contract to maintain the roads in Surrey, UKTo improve the road network and public realm for 1 million people near London A 10-year contract worth £600 million (€710 million), with a 11-year extension possibilitySurrey County Council has awarded the contract covering maintenance and upgrade of its road infrastructure to Ringway, a VINCI Construction subsidiary based in the UK. This contract encompasses some 560 km (350 miles) of roads and 290 km (180 miles) of pavements in the South West of London. Ringway will provide major maintenance services and emergency response, plus a variety of upgrading works to improve connections and access to this road network. The contract, worth £60 million (€71 million) per year, will begin on 27 April 2022 for an initial period of 10 years, with a 11-year...

Paris, November 4, 2021 Quadient (Euronext Paris: QDT), a leader in helping businesses create meaningful customer connections through digital and physical channels, today announced it has been ranked 11th in the 2021 edition of the EY/Numeum Top 250 French software publishers and developers. The Top 250, published by consultancy firm EY and professional software industry association Numeum, evaluated 269 companies according to their software publishing revenue. Quadient moved up one place in the overall ranking from 2020 and placed fifth in the Horizontal French Publishers’ Category, reaching the top 5% of publishers in the market. In addition to the annual ranking of French software publishers, the study analyzed the impact of the pandemic on the investment choices and the evolution of the software solutions offered by French companies...

        “We have seen the first encouraging results from the ongoing tasquinimod trial in multiple myeloma and started a new combination study with naptumomab and docetaxel in lung cancer” THIRD QUARTER IN BRIEF •  Active Biotech provided status update of its clinical naptumomab project on July 5•  Active Biotech’s partner NeoTX hosted KOL webinar on overcoming checkpoint inhibitor resistance on    July 8 EVENTS AFTER THE END OF THE PERIODTasquinimod clinical development in multiple myeloma advanced into combination therapy following completion of the initial phase of the ongoing trial in the US (Oct 3) Active Biotech and NeoTX announced that the first patient had been enrolled in the phase IIa clinical trial of naptumomab estafenatox in combination with docetaxel in patients with advanced non-small cell lung cancer (NSCLC) (Oct 20)Financial...